Code Information Sessions

The Ethics and Compliance Team offers a series of Code Information Sessions to members, non-members, and businesses/individuals working with the pharmaceutical industry anyone interested. These workshops are online, free, and available to all. Membership of Medicines Australia is not a pre-requisite to attend however there in most of the sessions there is an assumed base knowledge of the Code.

The Ethics and Compliance Team advertise these events through our communication channels including social media, and also directly to our members. Registrations open one month prior to the event. Code Information Sessions usually consist of an online presentation and allowing for questions-and-answers. The events are usually held on Thursday mornings from 10:30am – 12pm.

More information available through the Ethics and Compliance Team via email codehelpdesk@medicinesaustralia.com.au


2026 Online Program

Educational Events and the Code – register here for this event.

Whether company initiated or company sponsored, all activities and events must align with the Principles of the Medicines Australia Code of Conduct. This session explains what that means in practice, highlighting the key requirements in Section 4 of the Code and outlining what companies need to consider across different types of events. We will guide through fundamentals related to venue selection, hospitality, travel and accommodation, speaker briefings, and sponsorship arrangements, and some of the more challenging areas as events continue to evolve in nature and complexity.


Conversations and the Code: Compliance and Decision-Making in the Digital Age.

In an era of automation, omnichannel engagement, and AI-driven insights, decision-making is evolving, but accountability remains firmly human. This session focuses on how digital technologies, including AI, are reshaping compliance processes and influencing decisions in medical affairs and promotional review. We’ll explore how companies can embrace innovation while staying aligned with the Medicines Australia Code of Conduct and maintaining robust governance.

Speakers TBA


Achieving Balance in Promotional Materials.

The Code requires companies to provide balanced, fair, and accurate information to support the appropriate use of medicines. This session explores how to achieve that balance in practice, including how to incorporate essential safety and precautionary information, when additional risk detail is needed to offset claims, and how to ensure materials align with Sections1.1 and 2.1 of the Code

Designed to strengthen ethical decisionmaking, the session also addresses emerging challenges such as digital PI, QR codes, and dynamic content, helping industry navigate evolving formats while maintaining compliance. 


Conversations and the Code: Misinformation, Disinformation and Information Gaps in relation to Prescription Medicines.

The spread of misinformation, disinformation and incomplete information about prescription medicines increasingly affects patients and can undermine appropriate use and public trust. While companies must not promote prescription medicines to the general public, the Code provides limited guidance on how industry should respond when public information is inaccurate or misleading, creating a practical and ethical tension. 

This session considers these challenges at a high level by exploring the concepts of misinformation, disinformation and information gaps, and discussing factors that may be taken into account when such issues emerge. It will also touch on contemporary contexts such as social and digital platforms, thirdparty commentary, media reporting and evolving sources of health information, encouraging reflection on ethical decisionmaking and alignment with the intent of the Code. 

Speakers TBA 


Previous Code Info Sessions

Some of the Info sessions are recorded and made available on our Code Resource Toolkit Some of these recordings are abridged version of the actual webinar, but capture key points.